PCVX Vaxcyte, Inc.
Price Chart
Executive Summary
Vaxcyte, Inc. (PCVX) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for June 15, 2026. The meeting will vote on the election of three Class III directors, the ratification of Deloitte & Touche LLP as the independent auditor, and the approval of executive compensation. The filing is routine and does not contain any material financial data or significant corporate actions.
Actionable Insight
Monitor the company's next 10-Q filing for any updates on financial performance or guidance, as this proxy statement contains no new financial information.
Key Facts
- The filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting.
- The meeting will be held on June 15, 2026.
- Proposals include the election of three Class III directors: Olivier Brandicourt, Halley Gilbert, and Grant E. Pickering.
- The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2026 will be ratified.
- The compensation of the named executive officers will be approved on an advisory basis.
- The Board recommends voting 'For' on all proposals.
- The filing is routine and does not contain any material financial data or significant corporate actions.
Financial Impact
No material financial impact. The filing is a routine administrative document.
Risk Factors
- The lack of new financial information or strategic updates in the filing means investors must wait for the next quarterly report for material updates.
- The advisory vote on executive compensation could be a point of contention for shareholders, although it is non-binding.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-173686 |
| Document: 0001193125-26-173686-index-headers.html | 0001193125-26-173686 |
| Document: 0001193125-26-173686-index.html | 0001193125-26-173686 |
| Document: 0001193125-26-173686.txt | 0001193125-26-173686 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
7d ago
|
Press Release
| $46.93 $48.76 | ▲ +3.90% | ▲ +3.49% | $46.33 (−1.28%) |
|
May 6, 2026
4w ago
|
8-K
| $51.48 $53.01 | ▼ −2.97% | ▼ −2.14% | $46.33 (+10.00%) |
|
Apr 23, 2026
6w ago
|
DEFA14A
| $59.49 $59.72 | ▲ +0.39% | ▲ +0.22% | $46.33 (−22.12%) |
|
Apr 1, 2026
10w ago
|
Insider Cluster
| $58.50 $58.38 | ▼ −0.21% | ▼ −0.28% | $46.33 (−20.80%) |
|
Mar 23, 2026
11w ago
|
Press Release
| $55.94 $54.67 | ▼ −2.27% | ▼ −1.91% | $46.33 (−17.18%) |
|
Feb 24, 2026
15w ago
|
8-K
| $63.04 $60.00 | ▼ −4.82% | ▼ −4.28% | $46.33 (−26.51%) |
|
Feb 24, 2026
15w ago
|
8-K
| $63.04 $60.00 | ▼ −4.82% | ▼ −4.28% | $46.33 (−26.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access